| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |